Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › About Us › Our Staff › Turna Ray

Turna Ray

Managing Editor, Precision Oncology News
Phone Number
+1-212-651-5626
Email
[email protected]
Turna Ray at Genomeweb / 360dx Turna Ray at Genomeweb / 360dx

Turna Ray has been covering the personalized medicine and molecular diagnostics industries for GenomeWeb since 2006. She closely tracks the evolving regulatory, reimbursement, and business environment for precision medicine products. 

Articles Authored by Turna Ray

Jun 04, 2020

Studies Show Potential of Video, Online Education to Expand Cancer Risk Genetic Test Access

Premium

The MAGENTA and ProGen trials showed that video-based and online education can increase the number of patients getting tested compared to traditional approaches.  

May 31, 2020

Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients

Two studies presented at ASCO's virtual annual meeting demonstrated the clinical utility of germline findings in guiding treatment decisions in cancer.

May 30, 2020

ASCO Presentations Highlight Advances in Antibody Treatments for Molecularly Defined Lung Cancers

The studies highlighted the activity of three drugs in NSCLC patients characterized by HER2 mutations, CECAM5 overexpression, and high PD-L1 expression.

May 29, 2020

Patients Having Ovaries Removed Without Clear Genetic, Medical Rationale, Study Suggests

Premium

Results from the PROMPT registry presented at ASCO showed that 10 to 15 percent of women with variants in genes not linked to ovarian cancer had oophorectomies.

May 28, 2020

Keytruda Efficacy Impresses Oncologists in First-Line, MSI-High Metastatic Colorectal Cancer

Based on an eight-month progression-free survival advantage in Keynote-177, oncologists said that Keytruda may be the new frontline option for this subset of patients. 

May 26, 2020

Genetic Testing Challenges in Oncology: Missed Mutations Highlight Somatic, Germline Test Difference

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.

May 21, 2020

Q&A: ACMG Work Group Hoping to Spark Discussion on Reporting Germline Findings From Tumor Testing

In an interview, Marilyn Li and Douglas Stewart discuss why ACMG has put forth points that doctors and labs should consider when presumed germline findings crop up in tumor testing.

May 12, 2020

NICE, NHS England's Pandemic Guideline Gives Temporary Access to Precision Oncology Treatments

Premium

The guideline, in effect for three months, gives access to many molecularly informed indications that NICE previously found not cost-effective or that it hasn't yet reviewed.

Apr 27, 2020

Amid COVID-19, Lower Cancer Diagnosis Rates Mean Fewer Patients Getting Molecular Tests, Treatment

Premium

Data amassed by analytics firm Diaceutics suggests fewer patients are coming into healthcare facilities and missing the chance for diagnosis, molecular testing, and treatment.

Apr 19, 2020

Despite FDA Guidance, CDx Providers Still Have Challenges in Seeking 'Therapeutic Group' Indication

Premium

While the guidance may lead to more streamlined CDx indications in precision oncology, test developers will still need to generate evidence, perhaps with limited pharma support.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.